跳至主要内容
临床试验/ACTRN12617001359325
ACTRN12617001359325尚未招募未知

Investigating the effects of the Safe & Sound Protocol (SSP) on frontal alpha asymmetry and motor skills in children aged 8-14 years with Autism.

aTrobe University0 个研究点目标入组 68 人开始时间: 2017年9月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
8 Years 至 14 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
aTrobe University

相似试验

招募中
1 期
Investigating the endolift method in the treatment of primary axillary hyperhidrosis
IRCT20200127046282N43Tehran University of Medical Sciences10
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementia
RPCEC00000410Center of Molecular Immunology (CIM)1,456
已完成
4 期
Self-administered fentanyl for birthing women.ChildbirthReproductive Health and Childbirth - Childbirth and postnatal care
ACTRN12609000006246Western Health50
进行中(未招募)
Unknown
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue Diseases
ISRCTN13586698ouna Aesthetics75
进行中(未招募)
不适用
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volume
ISRCTN72858148Sinclair Pharma68